Global Urokinase Market Growth 2025-2031

Global Urokinase Market Growth 2025-2031

The global Urokinase market size is predicted to grow from US$ 48.7 million in 2025 to US$ 66.7 million in 2031; it is expected to grow at a CAGR of 5.4% from 2025 to 2031.

Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.

Global key players of urokinase include Syner-Med, LIVZON, Wanhua Biochem, etc. The top three players hold a share about 50%. China is the largest market of Urokinase, holding a share about 56%, followed by Europe and North America.

LP Information, Inc. (LPI) ' newest research report, the “Urokinase Industry Forecast” looks at past sales and reviews total world Urokinase sales in 2024, providing a comprehensive analysis by region and market sector of projected Urokinase sales for 2025 through 2031. With Urokinase sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Urokinase industry.

This Insight Report provides a comprehensive analysis of the global Urokinase landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Urokinase portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Urokinase market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Urokinase and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Urokinase.

This report presents a comprehensive overview, market shares, and growth opportunities of Urokinase market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Urokinase Powder
Urokinase Solution

Segmentation by Application:
Hospital
Clinic
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Syner-Med
Wanhua Biochem
Jiangxi Haoran Bio-Pharma
Jiangsu Aidea Pharmaceutical
Techpool
Microbic Biosystems
LIVZON

Key Questions Addressed in this Report

What is the 10-year outlook for the global Urokinase market?

What factors are driving Urokinase market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Urokinase market opportunities vary by end market size?

How does Urokinase break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver. Show more